Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2025 Earnings Call Transcript November 4, 2025
Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were $-0.72.
Operator: “
David Connolly: “
David Meeker: “
Jennifer Chien: “
Yann Mazabraud: “
Hunter Smith: “
Michael Ulz: ” Morgan Stanley, Research Division
Philip Nadeau: ” TD Cowen, Research Division
Derek Archila: ” Wells Fargo Securities, LLC, Research Division
Angela Qian: ” Canaccord...
